STERIS (STE) Director Esther M. Alegria Receives Awards (Options & RSUs)

What Happened

• Esther M. Alegria, a director of STERIS plc (STE), received two compensatory derivative awards on 2026-08-10: 1,506 nonqualified stock options and 512 Career Restricted Stock Units (RSUs). The Form 4 reports an acquisition price of $0.00 for both awards (typical for grants); no open‑market purchase or sale occurred. These are awards/compensation rather than purchases that would signal immediate market conviction.

Key Details

• Transaction date: 2026-08-10; Form filed: 2026-08-12 (timely).
• Awards: 1,506 nonqualified stock options (derivative) and 512 Career RSUs (derivative) — total rights to 2,018 shares.
• Reported acquisition price: $0.00 for both grants (compensatory awards).
• Shares owned after transaction: not specified in the provided filing summary.
• Footnotes of note:
  • F1: The nonqualified stock options are fully vested and exercisable immediately.
  • F2/F3: Each Career RSU represents the right to one ordinary share and is fully vested now but will be settled in STERIS shares six months after the director's Board service ends.
• Filing timeliness: Reported on Form 4 within the normal two-business-day window (no late filing flag).

Context

• The options are exercisable immediately per the filing, but exercising would typically require paying any applicable exercise price (not shown here) and possibly trigger tax/withholding events. The Career RSUs are vested but have a delayed settlement condition (paid in shares six months after the director leaves the board).
• These types of grants are routine director compensation and are not the same as open‑market purchases or insider sales; they do not by themselves signal the director buying or selling stock in the market.